Phage Therapy: Beyond Antibacterial Action

Until recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on p...

Full description

Bibliographic Details
Main Authors: Andrzej Górski, Ewa Jończyk-Matysiak, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Marzanna Łusiak-Szelachowska, Natalia Bagińska, Jan Borysowski, Małgorzata B. Łobocka, Alicja Węgrzyn, Grzegorz Węgrzyn
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2018.00146/full
id doaj-7f5687ddec264ea9897457ca9b3395f7
record_format Article
spelling doaj-7f5687ddec264ea9897457ca9b3395f72020-11-24T21:10:28ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-05-01510.3389/fmed.2018.00146369809Phage Therapy: Beyond Antibacterial ActionAndrzej Górski0Andrzej Górski1Andrzej Górski2Ewa Jończyk-Matysiak3Ryszard Międzybrodzki4Ryszard Międzybrodzki5Ryszard Międzybrodzki6Beata Weber-Dąbrowska7Beata Weber-Dąbrowska8Marzanna Łusiak-Szelachowska9Natalia Bagińska10Jan Borysowski11Małgorzata B. Łobocka12Małgorzata B. Łobocka13Alicja Węgrzyn14Grzegorz Węgrzyn15Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandPhage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandPhage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandPhage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, PolandInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, PolandAutonomous Department of Microbial Biology, Faculty of Agriculture and Biology, Warsaw University of Life Sciences, Warsaw, PolandLaboratory of Molecular Biology, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Gdańsk, PolandDepartment of Molecular Biology, University of Gdańsk, Gdańsk, PolandUntil recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on phage biology has shed more light on the significance of phages. Accumulating data indicate that phages may also interact with eukaryotic cells. How such interactions could be translated into advances in medicine (especially novel means of therapy) is discussed herein.https://www.frontiersin.org/article/10.3389/fmed.2018.00146/fullphagephage therapyimmunomodulationinflammationprophage induction
collection DOAJ
language English
format Article
sources DOAJ
author Andrzej Górski
Andrzej Górski
Andrzej Górski
Ewa Jończyk-Matysiak
Ryszard Międzybrodzki
Ryszard Międzybrodzki
Ryszard Międzybrodzki
Beata Weber-Dąbrowska
Beata Weber-Dąbrowska
Marzanna Łusiak-Szelachowska
Natalia Bagińska
Jan Borysowski
Małgorzata B. Łobocka
Małgorzata B. Łobocka
Alicja Węgrzyn
Grzegorz Węgrzyn
spellingShingle Andrzej Górski
Andrzej Górski
Andrzej Górski
Ewa Jończyk-Matysiak
Ryszard Międzybrodzki
Ryszard Międzybrodzki
Ryszard Międzybrodzki
Beata Weber-Dąbrowska
Beata Weber-Dąbrowska
Marzanna Łusiak-Szelachowska
Natalia Bagińska
Jan Borysowski
Małgorzata B. Łobocka
Małgorzata B. Łobocka
Alicja Węgrzyn
Grzegorz Węgrzyn
Phage Therapy: Beyond Antibacterial Action
Frontiers in Medicine
phage
phage therapy
immunomodulation
inflammation
prophage induction
author_facet Andrzej Górski
Andrzej Górski
Andrzej Górski
Ewa Jończyk-Matysiak
Ryszard Międzybrodzki
Ryszard Międzybrodzki
Ryszard Międzybrodzki
Beata Weber-Dąbrowska
Beata Weber-Dąbrowska
Marzanna Łusiak-Szelachowska
Natalia Bagińska
Jan Borysowski
Małgorzata B. Łobocka
Małgorzata B. Łobocka
Alicja Węgrzyn
Grzegorz Węgrzyn
author_sort Andrzej Górski
title Phage Therapy: Beyond Antibacterial Action
title_short Phage Therapy: Beyond Antibacterial Action
title_full Phage Therapy: Beyond Antibacterial Action
title_fullStr Phage Therapy: Beyond Antibacterial Action
title_full_unstemmed Phage Therapy: Beyond Antibacterial Action
title_sort phage therapy: beyond antibacterial action
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2018-05-01
description Until recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on phage biology has shed more light on the significance of phages. Accumulating data indicate that phages may also interact with eukaryotic cells. How such interactions could be translated into advances in medicine (especially novel means of therapy) is discussed herein.
topic phage
phage therapy
immunomodulation
inflammation
prophage induction
url https://www.frontiersin.org/article/10.3389/fmed.2018.00146/full
work_keys_str_mv AT andrzejgorski phagetherapybeyondantibacterialaction
AT andrzejgorski phagetherapybeyondantibacterialaction
AT andrzejgorski phagetherapybeyondantibacterialaction
AT ewajonczykmatysiak phagetherapybeyondantibacterialaction
AT ryszardmiedzybrodzki phagetherapybeyondantibacterialaction
AT ryszardmiedzybrodzki phagetherapybeyondantibacterialaction
AT ryszardmiedzybrodzki phagetherapybeyondantibacterialaction
AT beataweberdabrowska phagetherapybeyondantibacterialaction
AT beataweberdabrowska phagetherapybeyondantibacterialaction
AT marzannałusiakszelachowska phagetherapybeyondantibacterialaction
AT nataliabaginska phagetherapybeyondantibacterialaction
AT janborysowski phagetherapybeyondantibacterialaction
AT małgorzatabłobocka phagetherapybeyondantibacterialaction
AT małgorzatabłobocka phagetherapybeyondantibacterialaction
AT alicjawegrzyn phagetherapybeyondantibacterialaction
AT grzegorzwegrzyn phagetherapybeyondantibacterialaction
_version_ 1716756458100490240